108 related articles for article (PubMed ID: 12494138)
1. [Apheresis of immunoglobulins - new approach to the treatment of severe dilated cardiomyopathy].
Konovalov GA; Belenkov IuN; Zvezdkin PV; Chebyshev AN; Semin SN; Kuznetsova IuV; Adamova IIu; Kipor SG; Pokrovskiĭ SN
Kardiologiia; 2002; 42(6):92-6. PubMed ID: 12494138
[TBL] [Abstract][Full Text] [Related]
2. Ig apheresis for the treatment of severe DCM patients.
Pokrovsky SN; Ezhov MV; Safarova MS; Saidova MA; Shitov VN; Afanasieva MI; Khaustov AI; Adamova IY; Afanasieva OI; Konovalov GA
Atheroscler Suppl; 2013 Jan; 14(1):213-8. PubMed ID: 23357167
[TBL] [Abstract][Full Text] [Related]
3. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
[TBL] [Abstract][Full Text] [Related]
4. Apheresis in the treatment of idiopathic dilated cardiomyopathy.
Winters JL
J Clin Apher; 2012; 27(6):312-9. PubMed ID: 22811302
[TBL] [Abstract][Full Text] [Related]
5. Immunoadsorption in patients with dilated cardiomyopathy.
Herda LR; Felix SB; Staudt A
Atheroscler Suppl; 2009 Dec; 10(5):126-8. PubMed ID: 20129390
[TBL] [Abstract][Full Text] [Related]
6. Immunoadsorption in dilated cardiomyopathy.
Dörffel WV; Wallukat G; Baumann G; Felix SB
Ther Apher; 2000 Jun; 4(3):235-8. PubMed ID: 10910026
[TBL] [Abstract][Full Text] [Related]
7. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
[TBL] [Abstract][Full Text] [Related]
8. Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension.
Dandel M; Wallukat G; Englert A; Hetzer R
Atheroscler Suppl; 2013 Jan; 14(1):203-11. PubMed ID: 23357166
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic left ventricular assist device and apheresis on dilated cardiomyopathy.
Matoba Y; Okubo H; Nosé Y
Artif Organs; 2004 Feb; 28(2):171-81. PubMed ID: 14961957
[TBL] [Abstract][Full Text] [Related]
10. Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column-A prospective, multicenter, randomized, within-patient and parallel-group comparative study to evaluate efficacy and safety.
Yoshikawa T; Baba A; Akaishi M; Wakabayashi Y; Monkawa T; Kitakaze M; Izumi T; Tomoike H
J Clin Apher; 2016 Dec; 31(6):535-544. PubMed ID: 26801483
[TBL] [Abstract][Full Text] [Related]
11. National Heart, Lung, and Blood Institute state of the science symposium in therapeutic apheresis-Therapeutic apheresis in cardiovascular disease.
Winters JL; Cooper LT; Ratcliffe NR; Wu Y; Moriarty PM
J Clin Apher; 2015 Jun; 30(3):183-7. PubMed ID: 25181584
[TBL] [Abstract][Full Text] [Related]
12. Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy.
Pankuweit S; Lüers C; Richter A; Ruppert V; Gelbrich G; Maisch B;
Eur J Clin Invest; 2015 Sep; 45(9):906-17. PubMed ID: 26094644
[TBL] [Abstract][Full Text] [Related]
13. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.
Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S
Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438
[TBL] [Abstract][Full Text] [Related]
14. Immunoadsorption in dilated cardiomyopathy.
Staudt A; Felix SB
Transfus Apher Sci; 2007 Oct; 37(2):187-90. PubMed ID: 18036989
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in therapeutic apheresis.
Bosch T
J Artif Organs; 2003; 6(1):1-8. PubMed ID: 14598117
[TBL] [Abstract][Full Text] [Related]
16. Improvement of cardiac function after immunoadsorption in patients with dilated cardiomyopathy.
Felix SB; Staudt A; Friedrich GB
Autoimmunity; 2001; 34(3):211-5. PubMed ID: 11908780
[TBL] [Abstract][Full Text] [Related]
17. Reduced oxidative stress in parallel to improved cardiac performance one year after selective removal of anti-beta 1-adrenoreceptor autoantibodies in patients with idiopathic dilated cardiomyopathy: data of a preliminary study.
Schimke I; Müller J; Dandel M; Gremmels HD; Bayer W; Wallukat B; Wallukat G; Hetzer R
J Clin Apher; 2005 Oct; 20(3):137-42. PubMed ID: 15892087
[TBL] [Abstract][Full Text] [Related]
18. Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption.
Wallukat G; Reinke P; Dörffel WV; Luther HP; Bestvater K; Felix SB; Baumann G
Int J Cardiol; 1996 May; 54(2):191-5. PubMed ID: 8803685
[TBL] [Abstract][Full Text] [Related]
19. Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up.
Dörffel WV; Wallukat G; Dörffel Y; Felix SB; Baumann G
Int J Cardiol; 2004 Dec; 97(3):529-34. PubMed ID: 15561344
[TBL] [Abstract][Full Text] [Related]
20. Plasma exchange for the patients with dilated cardiomyopathy in children is safe and effective in improving both cardiac function and daily activities.
Moriguchi T; Koizumi K; Matsuda K; Harii N; Goto J; Harada D; Sugawara H; Hoshiai M; Kise H; Baba A
J Artif Organs; 2017 Sep; 20(3):236-243. PubMed ID: 28382424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
